Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its ...

Johnson & Johnson (JNJ) closed the most recent trading day at $209.72, moving +2.61% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.16%. On the other hand, the Dow ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price is back in rally mode. It is still early in the game, but the Q2 results ...

Johnson & Johnson (NYSE:JNJ) is among the most profitable US stocks to buy. On January 9, Lee Hambright at Bernstein raised ...

Johnson & Johnson (NYSE:JNJ – Free Report) had its target price lifted by Bank of America from $161.00 to $175.00 in a report issued on Thursday morning,Benzinga reports. The brokerage currently has a ...

Recent chatter on X about Johnson & Johnson (JNJ) has been buzzing with reactions to the company's latest earnings report and raised 2024 guidance. Posts highlight a notable 6% stock price increase ...

If you are wondering whether Johnson & Johnson shares still offer solid value after a strong run, this article will walk ...

CHONGQING, CHINA - JULY 13: In this photo illustration, a smartphone displaying the logo of Johnson & Johnson (NYSE: JNJ), a leading American multinational corporation known for pharmaceuticals, ...

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s JNJ stock price is back in rally mode. It is still early in the game, but the Q2 results affirm ...